New shot aims to protect kidneys from silent disease
NCT ID NCT07354932
Summary
This study is testing whether an experimental injection called SHR-2173 can help control IgA nephropathy, a kidney disease where protein leaks into the urine. About 84 adults with the disease will receive either the real injection or a placebo (dummy shot) for 48 weeks to see if it safely reduces urine protein and protects kidney function. Researchers will measure protein levels in urine and track how well the kidneys are working.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY IGA NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
Contact
-
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
Contact
Conditions
Explore the condition pages connected to this study.